MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Multi-Pathogen Vaccine Kit
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Multi-Pathogen Vaccine Kit
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
  •  
  • Uncategorized

AIVITA Biomedical Presents New Clinical Data at 2019 ASCO Annual Meeting

AIVITA Biomedical to Present at 2019 BIO International Convention Detailing New Clinical Data from Phase 2 Glioblastoma Trial

AIVITA Biomedical to Present at Oncology, Biotech and Aesthetics Conferences in June

AIVITA Biomedical to Present at Aesthetics and Regenerative Medicine Conferences in May

AIVITA Biomedical Expands Japan Distribution of its ROOT of SKIN™ Skincare Line

AIVITA Biomedical Partners with Guthy-Renker For ROOT of SKIN™ Product Line

AIVITA Biomedical to Present Biomarker Findings at 2019 AACR Annual Meeting

ROOT OF SKIN™ Skincare Line Sets New Sales Record on QVC Japan

AIVITA Biomedical to Present Cancer Vaccine Data at 2019 ASCO-SITC Clinical Immuno-Oncology Symposium

AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial

  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target infectious diseases and tumor-initiating cells — the seed of all cancers — using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development in cancer, infectious disease and other fields.

Recent News

  • AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis
  • AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress
  • AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2023 | AIVITA Biomedical, Inc.